Global Information
회사소개 | 문의 | 비교리스트

세계의 단일세포 게노믹스 및 프로테오믹스 시장(-2023년)

Global Single Cell Genomics and Proteomics Market, Forecast to 2023

리서치사 Frost & Sullivan
발행일 2019년 09월 상품 코드 911378
페이지 정보 영문 71 Pages
가격
US $ 1,500 ₩ 1,715,000 Web Access (Regional License) help
리서치사의 웹사이트에 로그인할 수 있는 패스워드가 발급되며, PDF를 다운로드 받는 형태로 제공됩니다. 동일 국가 내에 있는 사업장의 모든 분들이 이용할 수 있는 라이선스이며, 이용 인원수 제한은 없습니다. 텍스트 등의 PDF 내용 편집은 불가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 단일세포 게노믹스 및 프로테오믹스 시장(-2023년) Global Single Cell Genomics and Proteomics Market, Forecast to 2023
발행일 : 2019년 09월 페이지 정보 : 영문 71 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 단일세포 게노믹스 및 프로테오믹스(Single Cell Genomics and Proteomics) 시장을 조사했으며, 주요 동향·시장 성장에 대한 각종 영향요인 분석, 주요 기술과 워크플로우, 용도·기술·워크플로우별 매출 예측, 미충족 요구와 과제, 단일세포 기술의 전망, 향후 용도, 주목 기업·기술, 성장 기회·성공 전략 분석 등을 정리하여 전해드립니다.

개요

시장 성장 촉진요인·억제요인

경쟁 환경

  • 기존 기업 : 애널리스트의 견해
  • 주요 기술과 워크플로우 : 경쟁 환경
  • 단일세포 분석 워크플로우와 기술

자금조달 동향

  • 자금조달 동향 : 단일세포 분석 스타트업 기업
  • 자금조달 동향 : 미국 리서치 센터
  • 미국 리서치 센터 : 전년대비 분석
  • 상업 자금
  • SCG 중심
  • 주요 제휴

성장 기회·권장 행동

  • 하이스루풋(High-Throughput) 플랫폼으로의 이동
  • 계산 툴에 대한 초점 확대
  • SCG의 새로운 용도 출현
  • 성공·성장을 위한 전략적 필수요건
  • Mission Bio : DNA 분리 플랫폼에서 선점자의 우위성 확보
  • 하이스루풋(High-throughput) 단일세포 분석 시장에서 유일한 유명 플랫폼
  • Fluidigm : 단일세포 분석 산업의 표준으로 인식되나, 경쟁의 출현에 의해 포지셔닝 약화
  • 1CellBio : 기계학습에 의한 단일세포 유전자 발현의 패턴 식별을 목표로 한다. 등

매출 예측

  • 매출 예측
  • 매출 예측 : 용도별
  • 매출 내역 : 기술·워크플로우별

미충족 요구·향후 도입 부문

  • 단일세포 분석 워크플로우의 과제
  • 과제
  • 향후 용도·이용 사례

향후 전망

  • 결론·향후 전망
  • 면책사항

부록

FROST & SULLIVAN 소개

KSA 19.09.27

Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place

Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. There is a constant quest for delivering the lowest cost per cell which is keeping the innovation curve high. Single cell technology developers continue to attract funds from venture capitalists, making it one of the attractive areas to invest in the life science industry. While advancements in the hardware side are addressing throughput and low cost per cell, complexity in the data analysis remains unaddressed, which leaves opportunities to develop analytical tools and bioinformatics pipeline for single cell analysis data. From an application standpoint, while most of the current applications for single cell analysis are restricted to translational research, biopharma applications present the second largest opportunity. Single cell analysis for clinical applications is a long-term opportunity and the company that focuses more on addressing this application will clearly gain the first-mover advantage.

This study analysis the global single cell genomic and proteomic technologies and workflows and identifies key application areas and concepts that can help companies steer their way toward running a successful business. Documented insights from single cell biologists and researchers have been studied to identify current and future applications across translational, biopharma, clinical, and basic research. The study covers an assessment of the market across workflows, technologies, geographic regions and applications. These assessments have been developed after carefully studying 23 companies that are currently offering and developing solutions for single cell isolation and analytical purposes.

Key Issues Addressed:

  • What is the future outlook for single cell technologies?
  • What specific applications offer growth opportunities that can be leveraged by existing and future participants?
  • What are the unmet needs and challenges in the single cell genomics and proteomics industry?
  • What types of technologies (e.g., droplet based) are poised for growth?
  • Who are the major companies offering high-, moderate-, and low-throughput solutions?
  • What applications are driving the update of single cell genomic technologies?
  • What are the strengths of companies offering single cell genomic and proteomic technologies?
  • How will the structure of the market change over time? Is it ripe for acquisitions?
  • How has the industry M&A evolved between various companies offering single cell genomics solutions?
  • Where are the major themes of partnership?
  • Who are the right customers/target audience for platforms?
  • What do they want? What are they willing to pay?
  • Did you mean to say ‘uptake' here? Please check.

Table of Contents

Executive Summary

  • Key Findings
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions this Study will Answer

Drivers & Restraints

  • Market Drivers
  • Market Restraints
  • Market Drivers and Restraints (continued)
  • Interest in Single Cell Genomics
  • Research Areas of Interest in Single Cell Analysis
  • Comparison of Traditional Cell Isolation Techniques

Competitive Landscape

  • Analyst's Take on Established Companies
  • Analyst's Take on Established Companies (continued)
  • Analyst's Take on Established Companies (continued)
  • Key Technologies and Workflow-Competitor Landscape
  • Single Cell Analysis Workflow Technology
  • Single Cell Analysis Workflow Technology (continued)
  • Single Cell Analysis Workflow Technology (continued)
  • Single Cell Analysis Workflow Technology (continued)

Funding Trends

  • Early-Stage Company Funding Trends for Single Cell Analysis
  • Early-Stage Company Funding Trends for Single Cell Analysis (continued)
  • U.S Research Center Funding Trends
  • U.S Research Center Funding (Y-o-Y) Analysis
  • Commercial Funding
  • SCG Cores Around the World
  • Key Partnerships
  • Key Partnerships (continued)

Growth Opportunities and Companies to Action (C2A)

  • Shift towards High-Throughput Platforms
  • Increased Focus on Computational Tools
  • Emergence of New Applications for SCG
  • Strategic Imperatives for Success and Growth
  • Mission Bio Gains the First-mover Advantage as the Only DNA Isolation Platform
  • The Only Renowned Platform in the Market for High-throughput Single Cell Analysis
  • While Seen as an Industry Standard for Single Cell Analysis, New Competitors can Weaken Fluidigm's Market Position
  • UK-based Company Set Out to Provide Competition to Existing Single Cell Companies
  • When Combined with Veridex CTC Cell Search Deparray, the Company's Solution Proves its Potential in the Clinical Setting
  • Commercially Launched in December 2018, 1CellBio Aims to Tap into Machine Learning to Identify Patterns of Gene Expression in Single Cells

Revenue Forecast

  • Single Cell Genomics and Proteomics Market-Revenue Forecast
  • Single Cell Genomics and Proteomics Market-Revenue Forecast by Application
  • Revenue Breakdown by Technology and Workflow

Unmet Needs and Future Application Areas

  • Challenges with Single Cell Analysis Workflows
  • Challenges
  • Future Applications and Use Cases
  • Future Applications and Use Cases (continued)

Future Outlook

  • Key Conclusions and Future Outlook
  • Legal Disclaimer

Appendix

  • Computational Tools
  • Computational Tools (continued)
  • List of Companies Mentioned in this Report
  • List of Exhibits
  • List of Exhibits (continued)

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top
전화 문의
F A Q